Dendritic cell-based vaccines for therapy of HPV16-induced tumours

Advances in Experimental Medicine and Biology

Volumn 495, Issue , 2001, Pages 359-363

  Bubeník, Jan ^a   Šímová, Jana ^a   Vonka, Vladimír ^a   Šmahel, Michal ^a   Mikyšková, Romana ^a   Mendoza, Luis ^a  

^a INSTITUTE OF MATHEMATICS   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE;

ADOPTIVE IMMUNOTHERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CANCER CELL CULTURE; CANCER IMMUNIZATION; CANCER INHIBITION; CANCER RECURRENCE; CANCER SURGERY; CARCINOMA; CELL LYSATE; CONFERENCE PAPER; CONTROLLED STUDY; DENDRITIC CELL; LEUKOCYTE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME; VIRUS CARCINOGENESIS; WART VIRUS;

ANIMALIA; HUMAN PAPILLOMAVIRUS TYPES;

EID: 0035697636     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-0685-0_51     Document Type: Conference Paper

References (5)

1. Interleukin 2 gene therapy of residual disease in mice carrying tumours induced by HPV16
2. Metastatic MHC class I negative mouse cells derived by transformation with human papillomavirus type 16: A model for studies on vaccination against papillomavirus-associated tumours
3. Bone marrow dendritic cell-based anticancer vaccines
4. Peritumoral administration of antigen-unstimulated bone marrow-derived dendritic cells inhibits tumour growth
5. Interleukin-2 gene therapy of surgical minimal residual tumour disease